Login / Signup
Letter: tenofovir may be superior to entecavir for treatment-naïve chronic hepatitis B patients.
Ji-Gan Wang
Rui Chen
Li-Chuan Wang
Published in:
Alimentary pharmacology & therapeutics (2021)
Keyphrases
</>
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
hepatitis b virus
peritoneal dialysis
prognostic factors
liver fibrosis